Ontruzant

Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
biosimilars
biologics
drug pricing
Roche
Herceptin
Amgen
Kanjinti
Viatris
Ogivri
Pfizer
Trazimera
Teva Pharmaceutical
Herzuma
Organon
Ontruzant
Merck launches Herceptin biosimilar in U.S.
Seeking Alpha
Wed, 04/15/20 - 10:55 am
Merck
Herceptin
Roche
biosimilar
Ontruzant
WHO Prequalifies its First Biosimilar
RAPS.org
Thu, 12/19/19 - 06:01 pm
WHO
biosimilars
Samsung Bioepis
Ontruzant
Roche
Herceptin
breast cancer
Samsung Bioepis' First Cancer Biosimilar Approved by the FDA
BioSpace
Mon, 01/21/19 - 11:51 pm
FDA
Samsung Bioepis
Ontruzant
biosimilars
Genentech
Herceptin
FDA Approves 17th Biosimilar, Third for Herceptin
RAPS.org
Fri, 01/18/19 - 09:44 pm
FDA
Merck
Samsung Bioepis
Ontruzant
biosimilars
Roche
Herceptin